导管切除作为心房动的第一线治疗方法
Maham F Karatela1, Hugh Calkins1
1Johns Hopkins Hospital, Department of Cardiology, United States of America.
Progress in cardiovascular diseases
|July 24, 2025
概括
导管切除现在是心房动的第一线治疗方法,为药物治疗提供了安全有效的替代方案. 本综述探讨了它对治疗结果和未来治疗这种常见心律失常的进展的影响.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 心房的治疗已经从药物转向了先进的导管切除技术.
- 技术进步提高了导管切除的安全性和有效性.
研究的目的:
- 审查心房的历史治疗方法.
- 评估导管切除作为心房动的第一线治疗方法.
- 讨论心房动管理的未来方向.
主要方法:
- 对心房动的导管切除研究的文献综述.
- 对心律失常复发,心血管结果和医疗保健利用情况的数据分析.
- 探索不断发展的导管切除技术.
主要成果:
- 导管切除是心房动的安全有效治疗方法.
- 它越来越多地被认为是精选患者群体的第一线治疗.
- 有证据支持它对患者结果和医疗保健资源使用的积极影响.
结论:
- 导管切除代表了心房动管理的重大进步.
- 它作为一线治疗的作用正在扩大.
- 持续的技术进步将进一步完善治疗策略.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
Cardiopulmonary Resuscitation IV: Pharmacological Management
78
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
78
Cardiopulmonary Resuscitation III: AED Use
70
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
70
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
996
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
996


